表紙
市場調査レポート

Jasco Pharmaceuticals, LLC.:製品パイプライン分析

Jasco Pharmaceuticals, LLC. - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 289832
出版日 ページ情報 英文 22 Pages
即納可能
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。
Back to Top
Jasco Pharmaceuticals, LLC.:製品パイプライン分析 Jasco Pharmaceuticals, LLC. - Product Pipeline Review - 2015
出版日: 2015年12月16日 ページ情報: 英文 22 Pages
概要

Jasco Pharmaceuticals, LLC. は小分子による腫瘍治療薬を開発するバイオ製薬会社で、 Pim キナーゼやカゼインキナーゼ(I,II)といった製品を提供しています。同社のPim キナーゼは様々な血液の悪性腫瘍や固形腫瘍の治療に活用されている独自のATP結合ポケットをもつタンパク質キナーゼです。また、カゼインキナーゼIは癌細胞の増殖を減らし、II はアポトーシス、血管形成、信号伝導、炎症の時に用いられるタンパク質キナーゼです。

当レポートでは、Jasco Pharmaceuticals, LLC.における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Jasco Pharmaceuticals, LLC.の基本情報

  • Jasco Pharmaceuticals, LLC.の概要
  • 主要情報
  • 企業情報

Jasco Pharmaceuticals, LLC.:R&Dの概要

  • 主な治療範囲

Jasco Pharmaceuticals, LLC.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

Jasco Pharmaceuticals, LLC.:パイプライン製品の概況

  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ
    • 創薬中の製品/併用療法モダリティ

Jasco Pharmaceuticals, LLC.:薬剤プロファイル

  • JP-11646
  • Small Molecules to Inhibit Pim Kinase for Oncology
  • Small Molecule to Inhibit Casein Kinase 2-Alpha for Oncology
  • Small Molecule to Inhibit Casein Kinase-1 for Oncology

Jasco Pharmaceuticals, LLC.:パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

Jasco Pharmaceuticals, LLC.:最近のパイプライン動向

Jasco Pharmaceuticals, LLC.:本社と子会社の所在地

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07878CDB

Summary

Global Markets Direct's, 'Jasco Pharmaceuticals, LLC. - Product Pipeline Review - 2015', provides an overview of the Jasco Pharmaceuticals, LLC.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Jasco Pharmaceuticals, LLC.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Jasco Pharmaceuticals, LLC. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Jasco Pharmaceuticals, LLC.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Jasco Pharmaceuticals, LLC.'s pipeline products

Reasons to buy

  • Evaluate Jasco Pharmaceuticals, LLC.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Jasco Pharmaceuticals, LLC. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Jasco Pharmaceuticals, LLC.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Jasco Pharmaceuticals, LLC. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Jasco Pharmaceuticals, LLC.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Jasco Pharmaceuticals, LLC. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Jasco Pharmaceuticals, LLC. Snapshot
    • Jasco Pharmaceuticals, LLC. Overview
    • Key Information
    • Key Facts
  • Jasco Pharmaceuticals, LLC. - Research and Development Overview
    • Key Therapeutic Areas
  • Jasco Pharmaceuticals, LLC. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Jasco Pharmaceuticals, LLC. - Pipeline Products Glance
    • Jasco Pharmaceuticals, LLC. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Jasco Pharmaceuticals, LLC. - Drug Profiles
    • JP-11646
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit Pim Kinase for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit Casein Kinase 2-Alpha for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit Casein Kinase-1 for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Jasco Pharmaceuticals, LLC. - Pipeline Analysis
    • Jasco Pharmaceuticals, LLC. - Pipeline Products by Target
    • Jasco Pharmaceuticals, LLC. - Pipeline Products by Route of Administration
    • Jasco Pharmaceuticals, LLC. - Pipeline Products by Molecule Type
    • Jasco Pharmaceuticals, LLC. - Pipeline Products by Mechanism of Action
  • Jasco Pharmaceuticals, LLC. - Recent Pipeline Updates
  • Jasco Pharmaceuticals, LLC. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Jasco Pharmaceuticals, LLC., Key Information
  • Jasco Pharmaceuticals, LLC., Key Facts
  • Jasco Pharmaceuticals, LLC. - Pipeline by Indication, 2015
  • Jasco Pharmaceuticals, LLC. - Pipeline by Stage of Development, 2015
  • Jasco Pharmaceuticals, LLC. - Monotherapy Products in Pipeline, 2015
  • Jasco Pharmaceuticals, LLC. - Preclinical, 2015
  • Jasco Pharmaceuticals, LLC. - Discovery, 2015
  • Jasco Pharmaceuticals, LLC. - Pipeline by Target, 2015
  • Jasco Pharmaceuticals, LLC. - Pipeline by Route of Administration, 2015
  • Jasco Pharmaceuticals, LLC. - Pipeline by Molecule Type, 2015
  • Jasco Pharmaceuticals, LLC. - Pipeline Products by Mechanism of Action, 2015
  • Jasco Pharmaceuticals, LLC. - Recent Pipeline Updates, 2015

List of Figures

  • Jasco Pharmaceuticals, LLC. - Pipeline by Top 10 Indication, 2015
  • Jasco Pharmaceuticals, LLC. - Pipeline by Stage of Development, 2015
  • Jasco Pharmaceuticals, LLC. - Monotherapy Products in Pipeline, 2015
  • Jasco Pharmaceuticals, LLC. - Pipeline by Top 10 Target, 2015
  • Jasco Pharmaceuticals, LLC. - Pipeline by Top 10 Route of Administration, 2015
  • Jasco Pharmaceuticals, LLC. - Pipeline by Top 10 Molecule Type, 2015
  • Jasco Pharmaceuticals, LLC. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top